Wasatch Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,600
Closed -$239K 312
2017
Q3
$239K Buy
+6,600
New +$188K ﹤0.01% 315
2017
Q2
Sell
-12,100
Closed -$232K 351
2017
Q1
$232K Hold
12,100
﹤0.01% 338
2016
Q4
$202K Hold
12,100
﹤0.01% 356
2016
Q3
$249K Sell
12,100
-9,000
-43% -$228K ﹤0.01% 347
2016
Q2
$646K Sell
21,100
-1,200
-5% -$41.7K 0.01% 333
2016
Q1
$831K Buy
+22,300
New +$840K 0.01% 333
2014
Q1
Sell
-132,960
Closed -$2.79M 396
2013
Q4
$2.79M Sell
132,960
-806,766
-86% -$20.4M 0.03% 293
2013
Q3
$22.1M Buy
939,726
+42,357
+5% +$1.2M 0.23% 134
2013
Q2
$24.1M Buy
+897,369
New +$26M 0.26% 123

Other funds holding MYGN